Literature DB >> 26213802

An Acid-Triggered Degradable and Fluorescent Nanoscale Drug Delivery System with Enhanced Cytotoxicity to Cancer Cells.

Jinxia An1, Xiaomei Dai1, Zhongming Wu2, Yu Zhao1, Zhentan Lu1, Qianqian Guo1, Xinge Zhang1, Chaoxing Li1.   

Abstract

To reduce side-effects of anticancer drugs, development of nanocarriers with precise biological functions is a critical requirement. In this study, the multifunctional nanoparticles combining imaging and therapy for tumor-targeted delivery of hydrophobic anticancer drugs were prepared via self-assembly of amphiphilic copolymers obtained using RAFT polymerization, specifically, acid-labile ortho ester and galactose. First, boron-dipyrromethene dye-conjugated chain transfer agent provides fluorescent imaging capability for diagnostic application. Second, nanoparticles were stable under physiological conditions but degraded in acidic tumor microenvironment, leading to enhanced anticancer efficacy. Third, the application of biocompatible glycopolymers efficiently increased the target-to-background ratio through carbohydrate-protein interactions. Data from cell viability, cellular internalization, flow cytometry, biodistribution and anticancer efficacy tests showed that the drug-loaded nanoparticles were capable of inhibiting cancer cell proliferation with significantly enhanced capacity. Our newly developed multifunctional nanoparticles may thus facilitate the development of effective drug delivery systems for application in diagnosis and therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26213802     DOI: 10.1021/acs.biomac.5b00693

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  6 in total

1.  A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer.

Authors:  Xin-Shuai Wang; De-Jiu Kong; Tzu-Yin Lin; Xiao-Cen Li; Yoshihiro Izumiya; Xue-Zhen Ding; Li Zhang; Xiao-Chen Hu; Jun-Qiang Yang; She-Gan Gao; Kit S Lam; Yuan-Pei Li
Journal:  Acta Pharmacol Sin       Date:  2017-05-29       Impact factor: 6.150

2.  Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy.

Authors:  Chandran Murugan; Kathirvel Rayappan; Ramar Thangam; Ramasamy Bhanumathi; Krishnamurthy Shanthi; Raju Vivek; Ramasamy Thirumurugan; Atanu Bhattacharyya; Srinivasan Sivasubramanian; Palani Gunasekaran; Soundarapandian Kannan
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

3.  Unlocking the Potential of Poly(Ortho Ester)s: A General Catalytic Approach to the Synthesis of Surface-Erodible Materials.

Authors:  Mathieu J-L Tschan; Nga Sze Ieong; Richard Todd; Jack Everson; Andrew P Dove
Journal:  Angew Chem Int Ed Engl       Date:  2017-12-04       Impact factor: 15.336

Review 4.  Using High Molecular Precision to Study Enzymatically Induced Disassembly of Polymeric Nanocarriers: Direct Enzymatic Activation or Equilibrium-Based Degradation?

Authors:  Gadi Slor; Roey J Amir
Journal:  Macromolecules       Date:  2021-01-26       Impact factor: 5.985

Review 5.  Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.

Authors:  Ewelina Piktel; Katarzyna Niemirowicz; Marzena Wątek; Tomasz Wollny; Piotr Deptuła; Robert Bucki
Journal:  J Nanobiotechnology       Date:  2016-05-26       Impact factor: 10.435

Review 6.  Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.

Authors:  Wei Wu; Li Luo; Yi Wang; Qi Wu; Han-Bin Dai; Jian-Shu Li; Colm Durkan; Nan Wang; Gui-Xue Wang
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.